Concepedia

Author

Ruijuan Luo

University of Michigan

Also Known As

Ruijuan Luo

19

Publications

532

Citations

10

H-Index

20

Concepts

All Affiliations

University of MichiganCenter for Drug Evaluation and ResearchWest Virginia UniversityUnited States Food and Drug Administration
RL

About

Ruijuan Luo is an author at University of Michigan specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

72

2

Pharmacology

3

3

126

3

Biochemistry

2

2

75

4

Social Sciences

1

1

11

5

Neuroscience

1

1

11

Ruijuan Luo

×

11

Publications

513

Citations

10

H-Index

YearCitations

Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development

Angelo Aguilar, Jianfeng Lü, Liu Liu,

Journal of Medicinal Chemistry

2017

193

Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations

Ruijuan Luo, Yan Li, Miao He,

International Journal of Pharmaceutics

2017

64

Measurement of <i>in vivo</i> Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract

Alex Yu, Jason Baker, Ann Fioritto,

Molecular Pharmaceutics

2016

52

Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial

Patrick E. Georgoff, Vahagn C. Nikolian, Tess Bonham,

Clinical Pharmacokinetics

2017

51

Transformable Capillary Electrophoresis for Oligosaccharide Separations Using Phospholipid Additives

Ruijuan Luo, Stephanie Archer‐Hartmann, Lisa Holland

Analytical Chemistry

2010

41

Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers

Jamie N. Connarn, Stephanie A. Flowers, Marisa Kelly,

The AAPS Journal

2017

29

Electrophoretic screening of ligands under suppressed EOF with an inert phospholipid coating

Christian M. White, Ruijuan Luo, Stephanie Archer‐Hartmann,

Electrophoresis

2007

28

Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3

Michael W. Wilson, Liming Shu, Vania Hinkovska‐Galcheva,

ACS Chemical Neuroscience

2020

18

Identification of non‐reported bupropion metabolites in human plasma

Jamie N. Connarn, Ruijuan Luo, Jim Windak,

Biopharmaceutics & Drug Disposition

2016

16

Pramipexole Derivatives as Potent and Selective Dopamine D<sub>3</sub> Receptor Agonists with Improved Human Microsomal Stability

Jianyong Chen, Cheng Jiang, Beth Levant,

ChemMedChem

2014

11

Page 1